Physician profile
Brian E Weirick
NPI 1669457966
$8,691.59
in general payments reported to CMS, 2019-2025
53 companies · $1,839 in 2025
The $1,839 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,125 · 2020: $391 · 2021: $196 · 2022: $1,190 · 2023: $1,707 · 2024: $2,245 · 2025: $1,839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,790.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,181.02 | 2022-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $1,079.87 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $1,049.40 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $467.14 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $438.94 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $428.55 | 2019-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $425.95 | 2020-2025 | Xifaxan |
| Pfizer INC. | $322.87 | 2019-2025 | |
| Dexcom, INC. | $258.98 | 2021-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $248.78 | 2019-2025 | |
| Abbott Laboratories | $247.17 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $217.00 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $190.60 | 2022-2025 | Rexulti |
| Amgen INC. | $169.20 | 2019-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.79 | 2019-2024 | Jardiance |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $139.79 | 2022-2025 | Apligraf, Affinity |
| Sanofi-Aventis U.S. LLC | $134.41 | 2019-2023 | |
| Corcept Therapeutics | $133.50 | 2024-2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $121.43 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $101.03 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Integra Lifesciences Corporation | $89.50 | 2019 | |
| Daiichi Sankyo INC. | $87.27 | 2019-2024 | Injectafer |
| Lundbeck LLC | $82.89 | 2024-2025 | Rexulti, Vyepti |
| Kci USA, INC. | $73.29 | 2019 | |
| Astellas Pharma US INC | $70.59 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $61.50 | 2021-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Allergan, INC. | $56.70 | 2019-2020 | |
| Esperion Therapeutics, INC. | $50.06 | 2021-2022 | |
| Next Science LLC | $44.11 | 2023 | Blastx, Xperience, Surgx |
| Tris Pharma INC | $42.49 | 2025 | Dyanavel Xr |
| Axsome Therapeutics, INC. | $42.12 | 2024-2025 | Auvelity |
| Advanced Oxygen Therapy INC. | $39.52 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Misonix INC | $37.09 | 2020-2021 | |
| Solventum Corporation | $31.57 | 2025 | Snap, Activ.A.C. |
| Abiomed | $29.87 | 2024 | Impella |
| Idorsia Pharmaceuticals US INC | $28.45 | 2024 | Quviviq |
| Bioventus LLC | $28.13 | 2022 | |
| Medtronic, INC. | $25.65 | 2024 | Intellis Adaptivestim |
| Janssen Pharmaceuticals, INC | $24.59 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $23.87 | 2022 | |
| Vanda Pharmaceuticals INC. | $23.49 | 2024 | Fanapt, Hetlioz |
| Inari Medical, INC. | $22.83 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teva Pharmaceuticals USA, INC. | $20.46 | 2023 | Austedo Xr |
| Ekos Corporation | $19.47 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.81 | 2022 | |
| Mylan Specialty L.P. | $16.61 | 2019 | |
| Kyowa Kirin, INC. | $15.91 | 2024 | Crysvita |
| Boston Scientific Corporation | $15.63 | 2019 | |
| Kerecis Limited | $15.48 | 2022 | |
| Amarin Pharma, INC. | $15.08 | 2019 | |
| Promius Pharma LLC | $12.17 | 2019 | |
| Organon LLC | $8.46 | 2025 | Nexplanon |
| Dynavax Technologies Corporation | $6.51 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Weirick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.